Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert F Storey

Showing results (11-20 of 401) with videos related to

Pageof 41
Sort By:
Nature Reviews. Cardiology|April 24, 2013
Antiplatelet therapy. Cangrelor succeeds, at last, in PCIRobert F Storey
Interventional Cardiology (London, England)|May 29, 2024
Individualising Antithrombotic Strategies for Acute and Chronic Coronary SyndromesRobert F Storey
Diabetes & Vascular Disease Research|October 22, 2010
What drives thrombogenesis despite antiplatelet therapy in diabetes mellitus?Robert F Storey
Thrombosis and Haemostasis|April 12, 2011
Education in atherothrombosisRobert F Storey
Heart (British Cardiac Society)|July 12, 2011
New P2Y₁₂ inhibitorsRobert F Storey
JACC. Cardiovascular Interventions|May 25, 2019
Does Risk of Premature Discontinuation of Dual-Antiplatelet Therapy Following PCI Attenuate With Increasing Age?Wael Sumaya, Robert F Storey
European Heart Journal|November 22, 2017
The challenges of antithrombotic therapy in patients with left ventricular thrombosisWael Sumaya, Robert F Storey
Current Pharmaceutical Design|June 26, 2012
Development and clinical use of prasugrel and ticagrelorShiraz Ahmad, Robert F Storey
European Heart Journal. Acute Cardiovascular Care|October 1, 2014
Dyspnoea management in acute coronary syndrome patients treated with ticagrelorGuido Parodi, Robert F Storey
Expert Review of Cardiovascular Therapy|July 1, 2016
Cangrelor for the management and prevention of arterial thrombosisRobert F Storey, Akanksha Sinha
Pageof 41

Showing results (11-20 of 401) with videos related to

Sort By:
Pageof 41
Nature Reviews. Cardiology|April 24, 2013
Antiplatelet therapy. Cangrelor succeeds, at last, in PCIRobert F Storey
Interventional Cardiology (London, England)|May 29, 2024
Individualising Antithrombotic Strategies for Acute and Chronic Coronary SyndromesRobert F Storey
Diabetes & Vascular Disease Research|October 22, 2010
What drives thrombogenesis despite antiplatelet therapy in diabetes mellitus?Robert F Storey
Thrombosis and Haemostasis|April 12, 2011
Education in atherothrombosisRobert F Storey
Heart (British Cardiac Society)|July 12, 2011
New P2Y₁₂ inhibitorsRobert F Storey
JACC. Cardiovascular Interventions|May 25, 2019
Does Risk of Premature Discontinuation of Dual-Antiplatelet Therapy Following PCI Attenuate With Increasing Age?Wael Sumaya, Robert F Storey
European Heart Journal|November 22, 2017
The challenges of antithrombotic therapy in patients with left ventricular thrombosisWael Sumaya, Robert F Storey
Current Pharmaceutical Design|June 26, 2012
Development and clinical use of prasugrel and ticagrelorShiraz Ahmad, Robert F Storey
European Heart Journal. Acute Cardiovascular Care|October 1, 2014
Dyspnoea management in acute coronary syndrome patients treated with ticagrelorGuido Parodi, Robert F Storey
Expert Review of Cardiovascular Therapy|July 1, 2016
Cangrelor for the management and prevention of arterial thrombosisRobert F Storey, Akanksha Sinha
Pageof 41